Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase IIB Study of Trimodality Management of Clinical T1bN0M0 Cancers of the Esophagus

NCT01217060 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT01217060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01217060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase IIB Study of Trimodality Management of Clinical T1bN0M0 Cancers of the Esophagus
Lead sponsor
M.D. Anderson Cancer Center
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2010
Completion date
June 14, 2020
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer